Prescriptions for a controversial new drug for Alzheimer's could run $56 billion a year, putting a significant financial burden on Medicare, the health insurance for the elderly.
Prospects for the president’s proposal are uncertain. Republicans decry its cost and argue that much of what the plan contains doesn't count as real infrastructure.